The pharmaceutical intermediates market is expected to reach US$ 37,290.33 million in 2028 from US$ 27,356.70 million in 2020. The market is estimated to grow with a CAGR of 4.2% from 2021-2028.
The pharmaceutical intermediates market has been analyzed on the basis of type, application, distribution channel, and region. The market based on region is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report emphasizes on parameters such as market trends, technological advancements, market dynamics, and leading company’s competitive landscape analysis to offers insights and in-depth analysis of the pharmaceutical intermediates market. It also includes the analysis of COVID-19 pandemic across the market in all the key regions.
Lucrative Regions for Pharmaceutical Intermediates Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rising Prevalence of Chronic Diseases and Infectious Diseases
Pharmaceutical intermediates are the building blocks of active pharmaceutical ingredients (APIs). These are raw materials that undergo molecular change or processing during bulk drug production. Thus, the requirement of pharmaceutical intermediates increases with the rise in demand for drugs to treat chronic diseases. As per the Centers for Disease Control and Prevention (CDC), 6 in 10 adults in the US suffer from at least one chronic disease such as cancer, heart disease, lung disease, stroke, neurological disease, diabetes, and kidney diseases. Moreover, 4 in 10 adults in the country have two or more chronic diseases. Additionally, according to the press release by the European Chronic Disease Alliance (ECDA), in 2014, 9 out of 10 people in Europe die due to chronic diseases. Thus, 70–80% of the total healthcare costs are spent on the management of chronic diseases.
The surging prevalence of infectious diseases, especially in Southeast Asia, is also likely to propel the demand for APIs in the coming years, eventually driving the growth of the pharmaceutical intermediate market. For instance, as per the Revised National Tuberculosis Control Programme Report, around 4.4 lakh patients died due to tuberculosis in India in 2018, that is 29% of the total 1.5 million deaths caused by the disease across the world. Thus, such high prevalence of chronic diseases and infectious diseases is bolstering the demand for drugs, eventually highlighting the need of pharmaceutical intermediates.
Type-Based Insights
The pharmaceutical intermediates market, by type, is segmented into GMP, and non GMP. The GMP segment held the largest share of the market in 2020, whereas the same segment is anticipated to register the highest CAGR of 4.4% in the market during the forecast period.
Pharmaceutical Intermediates Market, by Type – 2020 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Application-Based Insights
The pharmaceutical intermediates market, by application, is segmented antibiotics, antipyretic analgesics, vitamins, and others. The antibiotics segment held the largest share of the market in 2020, also, this segment is anticipated to register the highest CAGR of 4.9% in the market during the forecast period.
Distribution Channel-Based Insights
On the basis of distribution channel, the pharmaceutical intermediates market has been segmented into distributor, and direct sales. The direct sales segment held the largest share of the market in 2020, and distributor segment is estimated to register the highest CAGR of 4.2% in the market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pharmaceutical Intermediates Market: Strategic Insights
Market Size Value in US$ 27,356.70 Million in 2020 Market Size Value by US$ 37,290.33 Million by 2028 Growth rate CAGR of 4.2% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pharmaceutical Intermediates Market: Strategic Insights
| Market Size Value in | US$ 27,356.70 Million in 2020 |
| Market Size Value by | US$ 37,290.33 Million by 2028 |
| Growth rate | CAGR of 4.2% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Companies operating in the pharmaceutical intermediates market are adopting organic strategies such as product launches and expansions to expand their footprint and product portfolio worldwide as well as to address the growing demands.
By Type
- GMP
- Non-GMP
By Application
- Antibiotics
- Antipyretic Analgesics
- Vitamins
- Others
By Distribution Channel
- Distributor
- Direct Sales
By Geography
North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- Italy
- United Kingdom
- Spain
- Switzerland
- Belgium
- Greece
- Norway
- Portugal
- Sweden
- Czech Republic
- Croatia
- Ireland
- Denmark
- Netherland
- Russia
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Pfizer, Inc
- Dishman Group
- Dextra Laboratories Limited
- Sanofi Winthrop Industries S.A.
- Vertellus Holdings LLC
- BASF SE
- Lianhetech
- Codexis
- Midas Pharma GmbH
- Chiracon GmbH
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type ; Applications ; Distribution Channel , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Belgium, Brazil, Canada, China, Croatia, Czech Republic, Denmark, France, Germany, Greece, India, Ireland, Italy, Japan, Mexico, Netherland, Norway, Portugal, RoAPAC, RoE, RoMEA, RoSCAM, Russian Federation, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Key factors that are driving the market are to rising prevalence of chronic diseases and infectious diseases, and escalating investment by pharmaceutical companies in R&D activities. However, high cost of drug manufacturing hinders the market growth.
Pharmaceutical intermediates are the raw materials used to manufacture active pharmaceutical ingredients for the final drug formulation. Pharmaceutical intermediates are used in the production of bulk drugs as well as for research and development purpose by various pharm and biopharma companies. Pharmaceutical intermediates are formed at the time of process of production or synthesis of active pharmaceutical ingredients.
The costs of the Pharmaceutical Intermediates are much higher, and they may cost US$ 5–50, or more, per kgs. The cost may also differ from product to product types.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Pharmaceutical Intermediates Market – By Type
1.3.2 Global Pharmaceutical Intermediates Market – By Application
1.3.3 Global Pharmaceutical Intermediates Market – By Distribution Channel
1.3.4 Global Pharmaceutical Intermediates Market– By Geography
2. Pharmaceutical Intermediates Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Pharmaceutical Intermediates Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 APAC PEST Analysis
4.2.4 MEA PEST Analysis
4.2.5 SCAM PEST Analysis
4.3 Expert Opinion
5. Pharmaceutical Intermediates Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Diseases and Infectious Diseases
5.1.2 Escalating R&D Investments by Pharmaceutical Companies
5.2 Market Restraints
5.2.1 High Cost of Manufacturing
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Increasing Adoption of AI-based Tools for Drug Discovery
5.5 Impact Analysis
6. Pharmaceutical Intermediates Market– Global Analysis
6.1 Global Pharmaceutical Intermediates Market Revenue Forecast and Analysis
6.2 Global Pharmaceutical Intermediates Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Pharmaceutical Intermediates Market Analysis – By Type
7.1 Overview
7.2 Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)
7.3 GMP
7.3.1 Overview
7.3.2 GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Non GMP
7.4.1 Overview
7.4.2 Non GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8. Pharmaceutical Intermediates Market Analysis – By Application
8.1 Overview
8.2 Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)
8.3 Antibiotics
8.3.1 Overview
8.3.2 Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Antipyretic Analgesics
8.4.1 Overview
8.4.2 Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Vitamins
8.5.1 Overview
8.5.2 Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8.6 Other
8.6.1 Overview
8.6.2 Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
9. Pharmaceutical Intermediates Market– By Distribution Channel
9.1 Overview
9.2 Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)
9.3 Distributor
9.3.1 Overview
9.3.2 Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Direct Sales
9.4.1 Overview
9.4.2 Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
10. Pharmaceutical Intermediates Market – Geographical Analysis
10.1 North America: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
10.1.1 Overview
10.1.2 North America: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.3 North America: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.4 North America: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.5 North America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6 North America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
10.1.7 US: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.1 US: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.2 US: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.7.3 US: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.7.4 US: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.8 Canada: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Canada: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Canada: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.8.3 Canada: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.8.4 Canada: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.9 Mexico: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.9.1 Mexico: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.9.2 Mexico: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.9.3 Mexico: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.9.4 Mexico: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.2 Europe: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
10.2.1 Overview
10.2.2 Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.2.4 Europe: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.2.5 Europe: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.6 Europe: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
10.2.7 Germany: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.2.7.1 Germany: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.2.7.2 Germany: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.2.7.3 Germany: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.2.7.4 Germany: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.8 UK: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.2.8.1 UK: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.2.8.2 UK: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.2.8.3 UK: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.2.8.4 UK: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.9 France: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.2.9.1 France: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.2.9.2 France: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.2.9.3 France: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.2.9.4 France: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.10 Spain: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.2.10.1 Spain: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.2.10.2 Spain: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.2.10.3 Spain: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.2.10.4 Spain: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.11 Italy: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.2.11.1 Italy: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.2.11.2 Italy: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.2.11.3 Italy: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.2.11.4 Italy: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.12 Rest of Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.2.12.1 Rest of Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.2.12.2 Rest of Europe: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.2.12.3 Rest of Europe: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.2.12.4 Rest of Europe: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.3 Asia Pacific: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
10.3.1 Overview
10.3.2 Asia Pacific: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.3.4 Asia Pacific: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.3.5 Asia Pacific: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.6 Asia Pacific: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
10.3.7 China: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.3.7.1 China: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.3.7.2 China: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.3.7.3 China: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.3.7.4 China: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.8 Japan: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.3.8.1 Japan: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.3.8.2 Japan: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.3.8.3 Japan: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.3.8.4 Japan: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.9 India: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.3.9.1 India: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.3.9.2 India: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.3.9.3 India: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.3.9.4 India: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.10 Australia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.3.10.1 Australia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.3.10.2 Australia: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.3.10.3 Australia: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.3.10.4 Australia: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.11 South Korea: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.3.11.1 South Korea: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.3.11.2 South Korea: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.3.11.3 South Korea: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.3.11.4 South Korea: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.12 Rest of Asia Pacific: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.3.12.1 Rest of Asia Pacific: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.3.12.2 Rest of Asia Pacific: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.3.12.3 Rest of Asia Pacific: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.3.12.4 Rest of Asia Pacific: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.4 Middle East & Africa: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
10.4.1 Overview
10.4.2 Middle East and Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.4.3 Middle East and Africa: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.4.4 Middle East and Africa: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.4.5 Middle East and Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.4.6 Middle East and Africa: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
10.4.7 Saudi Arabia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.4.7.1 Saudi Arabia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.4.7.2 Saudi Arabia: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.4.7.3 Saudi Arabia: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.4.7.4 Saudi Arabia: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.4.8 UAE: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.4.8.1 UAE: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.4.8.2 UAE: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.4.8.3 UAE: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.4.8.4 UAE: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.4.9 South Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.4.9.1 South Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.4.9.2 South Africa: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.4.9.3 South Africa: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.4.9.4 South Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.4.10 Rest of Middle East and Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.4.10.1 Rest of Middle East and Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.4.10.2 Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.4.10.3 Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.4.10.4 Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.5 South and Central America: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
10.5.1 South and Central America: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.5.2 South and Central America: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.5.3 South and Central America: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.5.4 South and Central America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.5.5 South and Central America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
10.5.6 Brazil: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1 Brazil: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2 Brazil: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.5.6.3 Brazil: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.5.6.4 Brazil: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.5.7 Argentina: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.5.7.1 Argentina: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.5.7.2 Argentina: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.5.7.3 Argentina: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.5.7.4 Argentina: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.5.8 Rest of South and Central America: Pharmaceutical Intermediates Market- Revenue and Forecasts to 2027 (USD Million)
10.5.8.1 Rest of South and Central America: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.5.8.2 Rest of South and Central America: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.5.8.3 Rest of South and Central America: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.5.8.4 Rest of South and Central America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Global Pharmaceutical Intermediates Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Pharmaceutical Intermediates Market– Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Pfizer Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sanofi
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BASF SE
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Lianhe Chemical Technology Co., Ltd.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Dishman Carbogen Amcis Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Codexis
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Midas Pharma GmbH
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 chiracon GmbH
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Dextra Laboratories Limited
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Vertellus Holdings LLC
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 4. US Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 5. US Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. US Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 13. Europe Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Europe Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 15. Europe Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 16. Germany Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 17. Germany Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 18. Germany Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 19. UK Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 20. UK Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 21. UK Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 22. France Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 23. France Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 24. France Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 25. Spain Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 26. Spain Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 27. Spain Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 28. Italy Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 29. Italy Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 30. Italy Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Europe Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Europe Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 34. Asia Pacific Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 35. Asia Pacific Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 36. Asia Pacific Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 37. China Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 38. China Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 39. China Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 40. Japan Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 41. Japan Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 42. Japan Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 43. India Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 44. India Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 45. India Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 46. Australia Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 47. Australia Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 48. Australia Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 49. South Korea Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 50. South Korea Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 51. South Korea Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Asia Pacific Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Asia Pacific Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Asia Pacific Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 55. Middle East and Africa Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 56. Middle East and Africa Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 57. Middle East and Africa Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 58. Saudi Arabia Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 59. Saudi Arabia Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 60. Saudi Arabia Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 61. UAE Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 62. UAE Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 63. UAE Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 64. South Africa Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 65. South Africa Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 66. South Africa Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 67. Rest of Middle East and Africa Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 68. Rest of Middle East and Africa Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Middle East and Africa Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 70. South and Central America Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 71. South and Central America Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 72. South and Central America Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 73. Brazil Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 74. Brazil Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 75. Brazil Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 76. Argentina Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 77. Argentina Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 78. Argentina Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 79. Rest of South and Central America Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 80. Rest of South and Central America Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 81. Rest of South and Central America Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 82. Organic Developments Done By Companies
Table 83. Inorganic Developments Done By Companies
Table 84. Glossary of Terms, Pharmaceutical Intermediates Market
LIST OF FIGURES
Figure 1. Pharmaceutical Intermediates Market Segmentation
Figure 2. Pharmaceutical Intermediates Segmentation, By Region
Figure 3. Global Pharmaceutical Intermediates Market Overview
Figure 4. GMP Held Largest Share of Type Segment in Pharmaceutical Intermediates Market
Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Pharmaceutical Intermediates Market, by Geography (US$ Million)
Figure 7. Global Pharmaceutical Intermediates Market– Leading Country Markets (US$ Million)
Figure 8. Global Pharmaceutical Intermediates Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. APAC: PEST Analysis
Figure 12. MEA: PEST Analysis
Figure 13. SCAM: PEST Analysis
Figure 14. Expert Opinion
Figure 15. Pharmaceutical Intermediates Market Impact Analysis of Driver and Restraints
Figure 16. Global Pharmaceutical Intermediates Market– Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Pharmaceutical Intermediates Market– By Geography Forecast and Analysis – 2020- 2028
Figure 18. Market Positioning of Key Players in Global Pharmaceutical Intermediates Market
Figure 19. Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)
Figure 20. GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Non GMP Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)
Figure 23. Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)
Figure 28. Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 29. Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. North America: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)
Figure 31. North America Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)
Figure 32. North America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
Figure 33. US: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Canada: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Mexico: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Europe: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)
Figure 37. Europe Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)
Figure 38. Europe: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
Figure 39. Germany: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. UK: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. France: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Spain: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Italy: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. Rest of Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 45. Asia Pacific: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)
Figure 46. Asia Pacific Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)
Figure 47. Asia Pacific: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
Figure 48. China: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Japan: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. India: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Australia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 52. South Korea: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 53. Rest of Asia Pacific: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 54. Middle East and Africa: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)
Figure 55. Middle East and Africa Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)
Figure 56. Middle East and Africa: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
Figure 57. Saudi Arabia: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. UAE: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. South Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. Rest of Middle East and Africa: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. South and Central America: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)
Figure 62. South and Central America Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)
Figure 63. South and Central America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
Figure 64. Brazil: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. Argentina: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. Rest of South and Central America: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. Impact of COVID-19 Pandemic in North American Country Markets
Figure 68. Impact of COVID-19 Pandemic in European Country Markets
Figure 69. Impact of COVID-19 Pandemic on Pharmaceutical Intermediates Market in Asia Pacific Countries
Figure 70. Impact of COVID-19 Pandemic in Middle East and Africa Market
Figure 71. Impact of COVID-19 Pandemic in South and Central America Market
Figure 72. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Pharmaceutical Intermediate Market
- Pfizer Inc.
- Sanofi
- BASF SE
- Lianhe Chemical Technology Co., Ltd
- Dishman Carbogen Amcis Ltd
- Codexis
- Midas Pharma GmbH
- chiracon GmbH
- Dextra Laboratories Limited
- Vertellus Holdings LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Pharmaceutical Intermediates Market
May 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
May 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
May 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)